Agenda

Back
DAY 1
Session III
Triple Negative Breast Cancer, Continued
Saturday, September 7, 2024
11:05 am
12:35 pm
Session Moderator(s)
PRESENTATION IN THIS SESSION

Promising Immunotherapy Hypotheses Targeting TNBC Biology: The Future

Rita Nanda, MD

Audience Q&A

Rita Nanda, MD

Novel Strategies Targeting TNBC Biology: The Future

Angela D. DiMichele, MD

Audience Q&A

Angela D. DiMichele, MD

Optimizing Host Factors in TNBC: Current and Future

Neil M. Iyengar, MD

Audience Q&A

Neil M. Iyengar, MD